Sign in

CIK 0001422143

  • Non-accelerated filer
  • Smaller reporting company

Kura Oncology, Inc.

Sign in to watch
Ticker
KURA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
611547851
Phone
+1 858-500-8800
Business address
4930 DIRECTORS PLACE, SUITE 500, SAN DIEGO, CA, 92121
Former names
ZETA ACQUISITION CORP III
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Planned sale Chief Operating Officer sold 526 shares at $16.03 ($8,434)
  4. 3 Insider Initial Statement of Ownership
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Planned sale Chief Legal Officer sold 2,615 shares at $22.15 ($57,916)
  13. 4 Open-market sale SVP, Finance & Accounting sold 2,318 shares at $17.80 ($41,262)
  14. 4 Open-market sale Chief Legal Officer sold 2,053 shares at $17.80 ($36,544)
  15. 4 Open-market sale Chief Operating Officer sold 1,496 shares at $17.80 ($26,630)
  16. 4 Open-market sale Chief Medical Officer sold 11,983 shares at an average $19.31 ($231,396)
  17. 4 Open-market sale President and CEO sold 91,052 shares at $20.23 ($1,841,982)
  18. 4 Grant or award SVP, Finance & Accounting acquired 21,250 shares (grant or award)
  19. 4 Grant or award Chief Commercial Officer acquired 15,000 shares (grant or award)
  20. 4 Derivatives Options or other derivatives

Page 5 of 14 · 277 filings